All in Health

Innovative healthcare payment and delivery to be piloted in North Carolina

To improve the health of Medicaid beneficiaries, and to reduce costs, the North Carolina Department of Health and Human Services is building an innovative health care delivery system with a payment structure that rewards better health outcomes, integrates physical and behavioral health, and invests in non-medical interventions. The effort is part of Managed Care Transformation.

Hospitals take more heat from Treasurer, calls for change in billing practices

State Treasurer Dale Folwell is once again sounding the alarm on some nonprofit hospitals in the state, with a new report that shows low-income patients are being billed when they were eligible for charity care. This comes on the heels of a similar report released in October by Folwell, who oversees the State Health Plan for government employees, the largest health insurance plan in the state.

Wait time for Moderna COVID-19 booster shortened to five months

The FDA now authorizes and the Centers for Disease Control and Prevention recommends individuals who received the Moderna COVID-19 vaccine get a booster dose after five months. This announcement from federal agencies comes just three days after the announcement of a shortened wait time for a booster from six months to five months for individuals who received the Pfizer vaccine.

Governor Cooper and NCDHHS Secretary Kinsley stress importance of vaccines and boosters to combat Omicron Variant

With cases of COVID-19 reaching record highs and hospitalizations increasing, Governor Roy Cooper and North Carolina Department of Health and Human Services Secretary Kody H. Kinsley called on all North Carolinians to get vaccinated and get a booster as soon as they are eligible to protect themselves from severe illness from the highly contagious Omicron variant of COVID-19.

FDA authorizes first oral antiviral for treatment of COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death

Health experts warn of significant impact from Omicron variant of COVID-19; NCDHHS urges everyone to get vaccinated

Health experts are warning that the highly contagious COVID-19 variant, Omicron, is expected to cause the greatest surge in COVID-19 infections to date in the coming months. The CDC and NCDHHS urge people to get vaccinated with an mRNA vaccine (Pfizer or Moderna) as soon as possible and to get a booster as soon as they are eligible to help prevent serious illness, hospitalization and death.